XTAI
2338
Market cap482mUSD
Oct 08, Last price
47.10TWD
1D
-1.46%
1Q
-1.26%
Jan 2017
445.14%
Name
Taiwan Mask Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1988 and headquartered in Hsinchu City, Taiwan, Taiwan Mask Corporation (TMC) is a key player in the semiconductor industry. The company primarily focuses on the research, development, manufacturing, and commercialization of critical components like photomasks and integrated circuits. Beyond production, TMC extends its expertise through a range of specialized services. These include technical assistance, advisory support, inspection, repair, and ongoing maintenance for masks and circuit technologies. The firm also offers comprehensive foundry services, as well as crucial packaging and testing solutions for semiconductors. Further diversifying its portfolio, Taiwan Mask Corporation also fabricates and markets medical equipment. Additionally, it acts as a distributor for electronic materials and high-precision equipment, engaging in both wholesale and retail channels for medical devices. With a significant global footprint, TMC operates extensively across Taiwan, various parts of Asia, the Americas, and other international markets.
Key people
Cheng-Hsiang Chen
Chairman of the Board · since 2020
Eve Yang
Group Chief Financial Officer, Senior Deputy General Manager · since 2024
Chief Executive Officer, General Manager, Director · since 2024
Chaucer Chung
Deputy General Manager · since 2023
Naster Huang
Senior Deputy General Manager · since 2025
Yuming Fan
Manager of Accounting · since 2024
Shu-Hua Lin
Head of Finance · since 2024
Chiao-Jin Tseng
Corporate Governance Officer · since 2024
Chairman of the Board · since 2025
Chao-Yi Wu
Director · since 2020
Independent Director · since 2022
Huan-Kuei Cheng
Independent Director · since 2021
Wei-Chen Wang
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||